The nitric oxide/cyclic GMP system at the supraspinal site is involved in the development of acute morphine antinociceptive tolerance

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 1, 1998, Pages 196-201

  Xu, Jimmy ^a   Hill, Kevin P ^a   Bidlack, Jean M ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; 7 NITROINDAZOLE; ARGININE; CYCLIC GMP; DEXTRO ARGININE; ISOSORBIDE DINITRATE; MORPHINE SULFATE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG TOLERANCE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; MALE; MICE; MICE, INBRED ICR; MORPHINE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; SPINAL CORD;

EID: 0031934837     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. G-nitro-L-arginine methyl ester. Life Sci 52:245-249.
2. Babey AM, Kolesnikov Y, Cheng J, Inturrisi CE, Trifilletti RR and Pasternak GW (1994) Nitric oxide and opioid tolerance. Neuropharmacology 33:1463-1470.
3. Bredt DS and Snyder SH (1992) Nitric oxide, a novel neuronal messenger. Neuron 8:3-11.
4. Cappenkijk SL, de Vries R and Dzoljic MR (1993) Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Neurosci Lett 162:97-100.
5. Deguchi T (1977) Endogenous activity factor for guanylyl cyclase in synaptosomal soluble fraction of the rat brain. J Biochem 252:7617-7619.
6. Dunbar S and Yaksh TL (1996) Effect of spinal infusion of L-NAME, a nitric oxide synthase inhibitor, on spinal tolerance and dependence induced by chronic intrathecal morphine in the rat. Neurosci Lett 207:33-36.
7. G-nitro-L-arginine, attenuate analgesic tolerance to the muopioid morphine but not to kappa opioids. Pain 56:69-75.
8. Garthwaite J (1991) Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci 14:60-67.
9. Gonzalez MC, Linares JD, Santos M and Llorente E (1996) Effects of nitric oxide donors sodium nitroprusside and 3-morpholino-sydnonimine on prolactin secretion in conscious rats. Neurosci Lett 203:167-170.
10. Haley TJ and McCormick WG (1957) Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br J Pharmacol Chemother 12:12-15.
11. 2-adrenergic receptors in rat brain. Nature 291:493-495.
12. 0 and other neuronal proteins by exposure to nitric oxide. Neuropharmacology 33:1283-1292.
13. Jiang Q, Seyed-Mozaffari A, Sebastian A, Archer S and Bidlack JM (1995) Preventing morphine antinociception tolerance by irreversible mu opioid antagonists before the onset of the their antagonism. J Pharmacol Exp Ther 273:680-688.
14. Kimes AS, Vaupel DB and London ED (1993) Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology 112:521-524.
15. G-Nitro-L-arginine prevents morphine tolerance. Eur J Pharmacol 221:399-400.
16. Kolesnikov YA, Pick CG, Ciszewska G and Pasternak GW (1993) Blockade of tolerance to morphine but not to K opioids by a nitric oxide synthase inhibitor. Proc Natl Acad Sci USA 90:5162-5166.
17. Llorens C, Martres MP, Baudry M and Schwarz JC (1978) Hypersensitivity to noradrenaline in cortex after chronic morphine: Relevance to tolerance and dependence. Nature 274:603-605.
18. Majeed NH, Przewlocki B, Machelska H and Przewlocki R (1994) Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology 33:189-192.
19. Malmberg AB and Yaksh TL (1993) Spinal nitric oxide synthesis inhibition blocks NMDA- induced thermal hyperalgesia and produces antinociception in the formalin test in rat. Pain 54:291-300.
20. Marek P, Ben-Eliyahu S, Vaccarino AL and Liebeskind JC (1991) Delayed application of MK-801 attenuates development of morphine tolerance in rats. Brain Res 558:163-165.
21. 2]deltorphin II in mice: Evidence for delta receptor subtypes. J Pharmacol. Exp Ther 258:583-587.
22. Melis MR and Argiolas A (1995) Nitric oxide donors induce penile erection and yawning when injected in the central nervous system of male rats. Eur J Pharmacol 294:1-9.
23. Moncada S, Palmer RMJ and Higs EA (1989) Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol 38:1709-1715.
24. G-Nitro-L-arginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol 102:198-202.
25. Murad F (1994) The role of nitric oxide in modulating guanylyl cyclase. Neurotransmissions 2:1-4.
26. Nathan C and Xie Q,-W (1994) Nitric oxide synthase: Roles, tolls and controls. Cell 78:915-918.
27. Przewlocki R, Machelska H and Przewlocki B (1993) Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord. Life Sci 53:PL 1-5.
28. Puttfarcken PS, Werling LL and Cox BM (1988) Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: A useful model for the study of tolerance at μ opioid receptors. Mol Pharmacol 33:520-527.
29. Roerig SC and Fujimoto JM (1989) Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice. J Pharmacol Exp Ther 249:762-768.
30. Salter M, Duffy C, Garthwaite J and Strijbos PJ (1995) Substantial regional and hemispheric differences in brain nitric oxide synthase (NOS) inhibition following intracerebroventricular administration of N-nitro-L-arginine (L-NA) and its methyl ester (L-NAME). Neuropharmacology 34:639-649.
31. Salter M, Duffy C, Garthwaite J and Strijbos PJ (1996) Ex vivo measurement of brain tissue nitrite and nitrate accurately reflects nitric oxide synthase activity in vivo. J Neurochem 66:1683-1690.
32. Satoh M, Zieglgansberger W and Herz A (1976) Supersensitivity of cortical neurons of the rats to acetylcholine and 1-glutamate following chronic morphine treatment. Naunyn-Schmiedeberg's Arch Pharmacol 293:101-103.
33. Schulz R and Herz A (1977) Naloxone-precipitated withdrawal reveals sensitization to neurotransmitters in morphine tolerant/dependent rats. Naunyn-Schmiedeberg's Arch Pharmacol 299:95-99.
34. Sharma SK, Klee WA and Nirenberg M (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci USA 72:3092-3096.
35. Stevens CW and Yaksh TL (1989) Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion. J Pharmacol Exp Ther 250:1-8.
36. Tallarida RJ and Murray RB (1986) Manual of Pharmacologic Calculations with Computer Programs. 2nd ed, Springer-Verlag, New York.
37. Tiseo P and Inturrisi CE (1993) Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614. J Pharmacol Exp Ther 264:1090-1096.
38. Trujillo KA and Akil H (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85-87.
39. Vaught JL and Takemori AE (1979) Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. J Pharmacol Exp Ther 208:86-90.
40. Xu JY and Tseng LF (1995) Nitric oxide/cyclic GMP system in the spinal cord differentially modulates intracerebroventricularly administered morphine- and β-endorphin-induced antinociception in the mouse. J Pharmacol Exp Ther 274:8-16.